Peter Svennilson, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 125,736 shares at $17.90 ($2.3M) on 2020-03-02, disclosed to the SEC on 2020-03-04.
Open-market purchase of $2.3M NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.90 | 14,124 | $253K | 11.2% |
| 2 | $17.90 | 14,124 | $253K | 11.2% |
| 3 | $17.99 | 38,758 | $697K | 30.9% |
| 4 | $17.99 | 38,758 | $697K | 30.9% |
| 5 | $17.96 | 9,986 | $179K | 7.9% |
| 6 | $17.96 | 9,986 |
| $179K |
| 7.9% |
| Total | $17.97 avg | 125,736 | $2.3M | 100% |
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |
| NGM | BUY | 2022-05-19 | $4.0M | — | Filing → |
| RAPT | SELL | 2021-08-24 | $5.4M | — | Filing → |